Jacobs Levy Equity Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,564
| Closed | -$280K | – | 991 |
|
|
2021
Q3 | $280K | Buy |
+4,564
| New | +$280K | ﹤0.01% | 944 |
|
|
2021
Q2 | – | Sell |
-9,910
| Closed | -$553K | – | 1049 |
|
|
2021
Q1 | $553K | Buy |
9,910
+4,675
| +89% | +$261K | ﹤0.01% | 850 |
|
|
2020
Q4 | $320K | Sell |
5,235
-768
| -13% | -$46.9K | ﹤0.01% | 912 |
|
|
2020
Q3 | $730K | Sell |
6,003
-1,517
| -20% | -$184K | 0.01% | 718 |
|
|
2020
Q2 | $889K | Buy |
7,520
+2,334
| +45% | +$276K | 0.01% | 695 |
|
|
2020
Q1 | $275K | Sell |
5,186
-6,116
| -54% | -$324K | ﹤0.01% | 837 |
|
|
2019
Q4 | $615K | Buy |
11,302
+7,576
| +203% | +$412K | 0.01% | 758 |
|
|
2019
Q3 | $903K | Buy |
3,726
+2,926
| +366% | +$709K | 0.01% | 628 |
|
|
2019
Q2 | $183K | Buy |
+800
| New | +$183K | ﹤0.01% | 883 |
|